β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Roberts LD, Boström P, O'Sullivan JF, Schinzel RT, Lewis GD, Dejam A, Lee YK, Palma MJ, Calhoun S, Georgiadi A, Chen MH, Ramachandran VS, Larson MG, Bouchard C, Rankinen T, Souza AL, Clish CB, Wang TJ, Estall JL, Soukas AA, Cowan CA, Spiegelman BM, Gerszten RE (2014) Cell Metab 19: 96-108 A decade of progress in adipose tissue macrophage biology. Hill AA, Reid Bolus W, Hasty AH (2014) Immunol Rev 262: 134-52 Macrophage-Targeted Therapeutics for Metabolic Disease. Peterson KR, Cottam MA, Kennedy AJ, Hasty AH (2018) Trends Pharmacol Sci 39: 536-546 Clinical implications of hemodialysis membrane biocompatibility. Hakim RM (1993) Kidney Int 44: 484-94 Acute kidney injury: changing lexicography, definitions, and epidemiology. Himmelfarb J, Ikizler TA (2007) Kidney Int 71: 971-6 The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy. Koethe JR, Grome H, Jenkins CA, Kalams SA, Sterling TR (2016) AIDS 30: 83-91 Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study. Liu J, Fox CS, Hickson D, Bidulescu A, Carr JJ, Taylor HA (2011) Arterioscler Thromb Vasc Biol 31: 2715-22 MMPs as therapeutic targets--still a viable option? Fingleton B (2008) Semin Cell Dev Biol 19: 61-8 Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, Amling M (2004) J Bone Miner Res 19: 2049-56 Chronic ethanol consumption inhibits postlactational anabolic bone rebuilding in female rats. Shankar K, Hidestrand M, Liu X, Chen JR, Haley R, Perrien DS, Skinner RA, Lumpkin CK, Badger TM, Ronis MJ (2008) J Bone Miner Res 23: 338-49 Calcitonin deficiency in mice progressively results in high bone turnover. Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF, Emeson RB, Rueger JM, Amling M (2006) J Bone Miner Res 21: 1924-34 Links between Immunologic Memory and Metabolic Cycling. Cottam MA, Itani HA, Beasley AA, Hasty AH (2018) J Immunol 200: 3681-3689 Anabolic interventions in ESRD: light at the end of the tunnel? Hakim RM, Ikizler TA (2009) Am J Kidney Dis 54: 201-4 Calcaneal ultrasound bone densitometry is not a useful tool to screen patients with inflammatory bowel disease at high risk for metabolic bone disease. Schwartz DA, Connolley CD, Koyama T, Wise PE, Herline AJ (2005) Inflamm Bowel Dis 11: 749-54 Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. Levasseur R, Barrios R, Elefteriou F, Glass DA, Lieberman MW, Karsenty G (2003) Endocrinology 144: 2761-4 Cytochromes p450: roles in diseases. Pikuleva IA, Waterman MR (2013) J Biol Chem 288: 17091-8 Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass. Walker EC, Johnson RW, Hu Y, Brennan HJ, Poulton IJ, Zhang JG, Jenkins BJ, Smyth GK, Nicola NA, Sims NA (2016) J Biol Chem 291: 21703-21716 Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer function. Shariat N, Holladay CD, Cleary RK, Phillips JA, Patton JG (2008) Clin Genet 74: 539-45 Evaluation of the metabochip genotyping array in African Americans and implications for fine mapping of GWAS-identified loci: the PAGE study. Buyske S, Wu Y, Carty CL, Cheng I, Assimes TL, Dumitrescu L, Hindorff LA, Mitchell S, Ambite JL, Boerwinkle E, Buzkova P, Carlson CS, Cochran B, Duggan D, Eaton CB, Fesinmeyer MD, Franceschini N, Haessler J, Jenny N, Kang HM, Kooperberg C, Lin Y, Le Marchand L, Matise TC, Robinson JG, Rodriguez C, Schumacher FR, Voight BF, Young A, Manolio TA, Mohlke KL, Haiman CA, Peters U, Crawford DC, North KE (2012) PLoS One 7: e35651 Metabolic bone disease in gastrointestinal illness. Williams SE, Seidner DL (2007) Gastroenterol Clin North Am 36: 161-90, viii Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study. Sinxadi PZ, Dave JA, Samuels DC, Heckmann JM, Maartens G, Levitt NS, Wester CW, Haas DW, Hulgan T (2013) AIDS Res Hum Retroviruses 29: 1031-9 Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation. Pashuck TD, Franz SE, Altman MK, Wasserfall CH, Atkinson MA, Wronski TJ, Flotte TR, Stalvey MS (2009) Pediatr Res 65: 311-6 Parenteral nutrition-associated metabolic bone disease. Seidner DL (2002) JPEN J Parenter Enteral Nutr 26: S37-42 Approach to assessing determinants of glucose homeostasis in the conscious mouse. Hughey CC, Wasserman DH, Lee-Young RS, Lantier L (2014) Mamm Genome 25: 522-38 Unmasked adult-onset urea cycle disorders in the critical care setting. Summar ML, Barr F, Dawling S, Smith W, Lee B, Singh RH, Rhead WJ, Sniderman King L, Christman BW (2005) Crit Care Clin 21: S1-8 Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate. Bonnick SL, Silverman S, Tanner SB, Martens M, Bachmann G, Kohles JD, Civitelli R (2009) J Womens Health (Larchmt) 18: 935-43 DOHaD at the intersection of maternal immune activation and maternal metabolic stress: a scoping review. Goldstein JA, Norris SA, Aronoff DM (2017) J Dev Orig Health Dis 8: 273-283
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.